HIVE TECHNOLOGIES INC. – Trademark Portfolio
Entity Type: 03
HIVE TECHNOLOGIES INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HIVE. The owner is based in HAWTHORNE, CA.
11909 HAWTHORNE BVD, STE 271
HAWTHORNE, CA 90250
Showing of trademarks Trademarks
Trademark Classifications
HIVE TECHNOLOGIES INC.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does HIVE TECHNOLOGIES INC. have?
HIVE TECHNOLOGIES INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does HIVE TECHNOLOGIES INC. file in?
HIVE TECHNOLOGIES INC. files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 36 (Insurance & Financial), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are HIVE TECHNOLOGIES INC.'s most well-known trademarks?
HIVE TECHNOLOGIES INC.'s registered trademark portfolio includes well-known marks such as HIVE. These are among 1 currently registered trademark in the portfolio.
What is HIVE TECHNOLOGIES INC.'s trademark registration success rate?
HIVE TECHNOLOGIES INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.